본문 바로가기
KERD
논문KCI 등재

Esophageal Mast Cell Infiltration in a 32-Year-Old Woman with Noncardiac Chest Pain

이슬기|권희진|이풍렬|Yang Won Min|Keol Lee|In Young Kim|Kwai Han Yoo
거트앤리버 소화기연관학회협의회|2016.01|Gut and Liver|제10권 제1호|pp. 152-155

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

Mast cellGastroesophageal refluxNoncardiac chest pain

초록

Noncardiac chest pain (NCCP) is one of the most common esophageal symptoms and lacks a clearly defined mechanism. The most common cause of NCCP is gastroesophageal reflux disease (GERD). One of the accepted mechanisms of NCCP in a patient without GERD has been altered visceral sensitivity. Mast cells may play a role in visceral hypersensitivity in irritable bowel syndrome. In this case, a patient with NCCP and dysphagia who was unresponsive to proton pump inhibitor treatment had an increased esophageal mast cell infiltration and responded to 14 days of antihistamine and antileukotriene treatment. We suggest that there may be a relationship between esophageal symptoms such as NCCP and esophageal mast cell infiltration.

Abstract

Noncardiac chest pain (NCCP) is one of the most common esophageal symptoms and lacks a clearly defined mechanism. The most common cause of NCCP is gastroesophageal reflux disease (GERD). One of the accepted mechanisms of NCCP in a patient without GERD has been altered visceral sensitivity. Mast cells may play a role in visceral hypersensitivity in irritable bowel syndrome. In this case, a patient with NCCP and dysphagia who was unresponsive to proton pump inhibitor treatment had an increased esophageal mast cell infiltration and responded to 14 days of antihistamine and antileukotriene treatment. We suggest that there may be a relationship between esophageal symptoms such as NCCP and esophageal mast cell infiltration.

참고문헌 (26)

  1. Fass R, "The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain", Gastroenterology, 115, pp.42~49 (1998)
  2. Van Handel D, "The pathophysiology of non-cardiac chest pain", J Gastroenterol Hepatol, 20(3), pp.S6~S13 (2005)
  3. Fass R, "Noncardiac chest pain", J Clin Gastroenterol, 42, pp.636~646 (2008)
  4. Traver E, "Mucosal mast cells mediate motor response induced by chronic oral exposure to ovalbumin in the rat gastrointestinal tract", Neurogastroenterol Motil, 22, pp.e34~e43 (2010)
  5. Miner PB Jr, "The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis", J Invest Dermatol, 96(3), pp.40S~43S (1991)
  6. Jakate S, "Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea", Arch Pathol Lab Med, 130, pp.362~367 (2006)
  7. Lee H, "Heterogeneity of mucosal mast cell infiltration in subgroups of patients with esophageal chest pain", Neurogastroenterol Motil, 26, pp.786~793 (2014)
  8. O’Sullivan M, "Increased mast cells in the irritable bowel syndrome", Neurogastroenterol Motil, 12, pp.449~457 (2000)
  9. Weston AP, "Terminal ileal mucosal mast cells in irritable bowel syndrome", Dig Dis Sci, 38, pp.1590~1595 (1993)
  10. Akhavein M A, "Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility", Gastroenterol Res Pract, 2012, pp.950582~ (2012)
  11. Park SW, "Esophageal mucosal mast cell infiltration and changes in segmental smooth muscle contraction in noncardiac chest pain", Dis Esophagus, 28, pp.512~519 (2015)
  12. Ford AC, "Meta-analysis: the epidemiology of noncardiac chest pain in the community", Aliment Pharmacol Ther, 34, pp.172~180 (2011)
  13. Richter JE, "Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy", Ann Intern Med, 110, pp.66~78 (1989)
  14. Fass R, "Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans", Gastroenterology, 115, pp.1363~1373 (1998)
  15. Klooker TK, "The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome", Gut, 59, pp.1213~1221 (2010)
  16. Deiteren A, "Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity", Gut, 63, pp.1873~1882 (2014)
  17. Cenac N, "Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity", Gut, 59, pp.481~488 (2010)
  18. Amadesi S, "Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia", J Neurosci, 24, pp.4300~4312 (2004)
  19. Sadofsky LR, "Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine", Exp Lung Res, 34, pp.681~693 (2008)
  20. Hellbom E, "Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment", Med Hypotheses, 66, pp.689~690 (2006)
  21. Dickman R, "The role of pain modulators in esophageal disorders: no pain no gain", Neurogastroenterol Motil, 26, pp.603~610 (2014)
  22. Yu Y, "Alterations of mast cells in the esophageal mucosa of the patients with non-erosive reflux disease", Gastroenterol Res, 4, pp.70~75 (2011)
  23. Siegert SI, "Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?", Am J Clin Pathol, 122, pp.560~565 (2004)
  24. Straumann A, "Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response", J Allergy Clin Immunol, 108, pp.954~961 (2001)
  25. Abonia JP, "Involvement of mast cells in eosinophilic esophagitis", J Allergy Clin Immunol, 126, pp.140~149 (2010)
  26. Liacouras CA, "Eosinophilic esophagitis: updated consensus recommendations for children and adults", J Allergy Clin Immunol, 128(e6), pp.3~20 (2011)

관련 논문AI추천

Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients박효진, 윤각원, 이유진, 정다현, 조윤주거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제1호Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel SyndromeDan Huang, Fa-Can Zhang, Guo Zhang, He-Sheng Luo, Lie-Xin Liang, Wen-Jing Liang거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제3호A Case of Eosinophilic Gastrointestinal Disorders Presenting with Chronic Diarrhea and Abdominal Pain이동률대한가정의학회 · Korean Journal of Family Medicine2011 · 제32권 제4호A Prospective Study of Eosinophilic Esophagitis and the Expression of Tight Junction Proteins in Patients with Gastroesophageal Reflux Disease SymptomsDaisuke Maruoka, Hideaki Ishigami, Keiko Saito, Kenichiro Okimoto, Makoto Arai, Masaki Suzuki, Osamu Yokosuka, Shoko Minemura, Tatsuro Katsuno, Tomoaki Matsumura, Tomoo Nakagawa, Yukio Nakatani거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제1호Eosinophilic Esophagitis in Adults: A Concise Overview of an Evolving DiseaseAfif Yaccob, Amir Mari, Emmanouela Tsoukali대한가정의학회 · Korean Journal of Family Medicine2020 · 제41권 제2호Esophageal Reflux Hypersensitivity: A Comprehensive ReviewFujiwara Yasuhiro, Sawada Akinari, Sifrim Daniel거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제6호

이 간행물의 다른 논문 (23건)

Proton Pump Inhibitor-Responsive Esophageal Eosinophilia: Controversies and Its Clinical Implications신철민, 이동호pp. 1-2Understanding the Role of Endoscopic Ultrasonography in Early Gastric Cancer이상길, 박찬혁pp. 3-5Do Esophageal Squamous Cell Carcinoma Patients Have an Increased Risk of Coexisting Colorectal Neoplasms?Moon Joo Hwang, 장병익pp. 6-7Changes in Hospital Admissions and Mortality for Complications of Cirrhosis: Implications for Clinicians and Health SystemsMichael E. Matheny, Bernd E. Schnabl, Samuel B. Hopp. 8-9Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic FibrosisYong Han Paikpp. 10-11
원문 보기